Advertisement
UK markets close in 7 hours 13 minutes

  • FTSE 100

    7,832.66
    -44.39 (-0.56%)
     

  • FTSE 250

    19,284.01
    -166.66 (-0.86%)
     

  • AIM

    740.67
    -4.62 (-0.62%)
     

  • GBP/EUR

    1.1681
    -0.0002 (-0.01%)
     

  • GBP/USD

    1.2440
    +0.0002 (+0.01%)
     

  • Bitcoin GBP

    52,072.01
    +2,999.26 (+6.11%)
     

  • CMC Crypto 200

    1,328.96
    +16.33 (+1.24%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • CRUDE OIL

    83.12
    +0.39 (+0.47%)
     

  • GOLD FUTURES

    2,396.90
    -1.10 (-0.05%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • HANG SENG

    16,245.82
    -140.05 (-0.85%)
     

  • DAX

    17,685.57
    -151.83 (-0.85%)
     

  • CAC 40

    7,973.02
    -50.24 (-0.63%)
     
Money:

Best mortgage deals of the week

As possibility of multiple interest rate cuts dwindle here's what banks and building societies are offering

BUZZ-SkyePharma: strong first-half boosts stock

Reuters - UK Focus

** The specialty pharmaceutical company's shares up 5.8 pct, making them top gainers on the FTSE Small Cap Index , after reporting strong H1 results and indicating a better-than-expected full year

** SkyePharma (LSE: SKP.L - news) reported a 19 pct rise in H1 revenue and said it expects continued substantial growth in revenues in 2015 compared with 2014

** 15 times daily avg trading volumes traded in first 30 mins

** Up to Tuesday's close, the stock had lost 20 pct YTD

** Finncap initiates coverage with "buy" recommendation and 351 p price target; says in absence of any value-enhancing M&A, sees 31 pct upside in one year

(Reuters Messaging: roshni.menon.thomsonreuters.com@reuters.net)